Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.32 | 2.27 |
NAV | ₹14.78 | ₹169.49 |
Fund Started | 26 Jul 2023 | 13 Oct 2005 |
Fund Size | ₹785.85 Cr | ₹1420.55 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -6.25% | 8.07% |
3 Year | - | 20.00% |
5 Year | - | 23.10% |
1 Year
3 Year
5 Year
Equity | 92.58% | 96.69% |
Cash | 3.01% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Samvardhana Motherson International Ltd. | 9.19% |
Aurobindo Pharma Ltd. | 8.98% |
Zydus Wellness Ltd. | 7.58% |
Adani Green Energy Ltd. | 7.36% |
Premier Energies Ltd. | 6.02% |
Gujarat Themis Biosyn Ltd. | 5.89% |
Ador Welding Ltd. | 5.17% |
Ravindra Energy Ltd. | 5.10% |
Anthem Biosciences Ltd. | 5.03% |
Bajaj Auto Ltd. | 4.53% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 07 Jul 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity and equity related instruments of companies that follow the manufacturing theme. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 26 Jul 2023 | 13 Oct 2005 |
Description
Launch Date